266 related articles for article (PubMed ID: 20042456)
1. Influence of genetic background on albuminuria and kidney injury in Ins2(+/C96Y) (Akita) mice.
Gurley SB; Mach CL; Stegbauer J; Yang J; Snow KP; Hu A; Meyer TW; Coffman TM
Am J Physiol Renal Physiol; 2010 Mar; 298(3):F788-95. PubMed ID: 20042456
[TBL] [Abstract][Full Text] [Related]
2. Loss of angiotensin-converting enzyme-2 (Ace2) accelerates diabetic kidney injury.
Wong DW; Oudit GY; Reich H; Kassiri Z; Zhou J; Liu QC; Backx PH; Penninger JM; Herzenberg AM; Scholey JW
Am J Pathol; 2007 Aug; 171(2):438-51. PubMed ID: 17600118
[TBL] [Abstract][Full Text] [Related]
3. A sensitized screen of N-ethyl-N-nitrosourea-mutagenized mice identifies dominant mutants predisposed to diabetic nephropathy.
Tchekneva EE; Rinchik EM; Polosukhina D; Davis LS; Kadkina V; Mohamed Y; Dunn SR; Sharma K; Qi Z; Fogo AB; Breyer MD
J Am Soc Nephrol; 2007 Jan; 18(1):103-12. PubMed ID: 17151334
[TBL] [Abstract][Full Text] [Related]
4. Deletion of p47phox attenuates the progression of diabetic nephropathy and reduces the severity of diabetes in the Akita mouse.
Liu GC; Fang F; Zhou J; Koulajian K; Yang S; Lam L; Reich HN; John R; Herzenberg AM; Giacca A; Oudit GY; Scholey JW
Diabetologia; 2012 Sep; 55(9):2522-32. PubMed ID: 22653270
[TBL] [Abstract][Full Text] [Related]
5. Integrin α1/Akita double-knockout mice on a Balb/c background develop advanced features of human diabetic nephropathy.
Yu L; Su Y; Paueksakon P; Cheng H; Chen X; Wang H; Harris RC; Zent R; Pozzi A
Kidney Int; 2012 Jun; 81(11):1086-97. PubMed ID: 22297672
[TBL] [Abstract][Full Text] [Related]
6. Deletion of the gene for adiponectin accelerates diabetic nephropathy in the Ins2 (+/C96Y) mouse.
Fang F; Bae EH; Hu A; Liu GC; Zhou X; Williams V; Maksimowski N; Lu C; Konvalinka A; John R; Scholey JW
Diabetologia; 2015 Jul; 58(7):1668-78. PubMed ID: 25957229
[TBL] [Abstract][Full Text] [Related]
7. Impact of genetic background on nephropathy in diabetic mice.
Gurley SB; Clare SE; Snow KP; Hu A; Meyer TW; Coffman TM
Am J Physiol Renal Physiol; 2006 Jan; 290(1):F214-22. PubMed ID: 16118394
[TBL] [Abstract][Full Text] [Related]
8. SOD1, but not SOD3, deficiency accelerates diabetic renal injury in C57BL/6-Ins2(Akita) diabetic mice.
Fujita H; Fujishima H; Takahashi K; Sato T; Shimizu T; Morii T; Shimizu T; Shirasawa T; Qi Z; Breyer MD; Harris RC; Yamada Y; Takahashi T
Metabolism; 2012 Dec; 61(12):1714-24. PubMed ID: 22632894
[TBL] [Abstract][Full Text] [Related]
9. Knockout of Na
Song P; Huang W; Onishi A; Patel R; Kim YC; van Ginkel C; Fu Y; Freeman B; Koepsell H; Thomson S; Liu R; Vallon V
Am J Physiol Renal Physiol; 2019 Jul; 317(1):F207-F217. PubMed ID: 31091127
[TBL] [Abstract][Full Text] [Related]
10. Arginase-2 mediates diabetic renal injury.
Morris SM; Gao T; Cooper TK; Kepka-Lenhart D; Awad AS
Diabetes; 2011 Nov; 60(11):3015-22. PubMed ID: 21926276
[TBL] [Abstract][Full Text] [Related]
11. Chronic COX inhibition reduces diabetes-induced hyperfiltration, proteinuria, and renal pathological markers in 36-week B6-Ins2(Akita) mice.
Nasrallah R; Robertson SJ; Hébert RL
Am J Nephrol; 2009; 30(4):346-53. PubMed ID: 19609076
[TBL] [Abstract][Full Text] [Related]
12. Assessment of diabetic nephropathy in the Akita mouse.
Chang JH; Gurley SB
Methods Mol Biol; 2012; 933():17-29. PubMed ID: 22893398
[TBL] [Abstract][Full Text] [Related]
13. Type 1 diabetic cardiomyopathy in the Akita (Ins2WT/C96Y) mouse model is characterized by lipotoxicity and diastolic dysfunction with preserved systolic function.
Basu R; Oudit GY; Wang X; Zhang L; Ussher JR; Lopaschuk GD; Kassiri Z
Am J Physiol Heart Circ Physiol; 2009 Dec; 297(6):H2096-108. PubMed ID: 19801494
[TBL] [Abstract][Full Text] [Related]
14. Reduction of Superoxide Dismutase 1 Delays Regeneration of Cardiotoxin-Injured Skeletal Muscle in KK/Ta-
Takahashi Y; Shimizu T; Kato S; Nara M; Suganuma Y; Sato T; Morii T; Yamada Y; Fujita H
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071003
[TBL] [Abstract][Full Text] [Related]
15. Characterization of diabetic nephropathy in a transgenic model of hypoinsulinemic diabetes.
Kanetsuna Y; Hirano K; Nagata M; Gannon MA; Takahashi K; Harris RC; Breyer MD; Takahashi T
Am J Physiol Renal Physiol; 2006 Dec; 291(6):F1315-22. PubMed ID: 16705146
[TBL] [Abstract][Full Text] [Related]
16. Role of the USF1 transcription factor in diabetic kidney disease.
Sanchez AP; Zhao J; You Y; Declèves AE; Diamond-Stanic M; Sharma K
Am J Physiol Renal Physiol; 2011 Aug; 301(2):F271-9. PubMed ID: 21543418
[TBL] [Abstract][Full Text] [Related]
17. High Elmo1 expression aggravates and low Elmo1 expression prevents diabetic nephropathy.
Hathaway CK; Chang AS; Grant R; Kim HS; Madden VJ; Bagnell CR; Jennette JC; Smithies O; Kakoki M
Proc Natl Acad Sci U S A; 2016 Feb; 113(8):2218-22. PubMed ID: 26858454
[TBL] [Abstract][Full Text] [Related]
18. The Ins2Akita mouse as a model of early retinal complications in diabetes.
Barber AJ; Antonetti DA; Kern TS; Reiter CE; Soans RS; Krady JK; Levison SW; Gardner TW; Bronson SK
Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2210-8. PubMed ID: 15914643
[TBL] [Abstract][Full Text] [Related]
19. Podocyte-specific knockout of cyclooxygenase 2 exacerbates diabetic kidney disease.
Wang L; Sha Y; Bai J; Eisner W; Sparks MA; Buckley AF; Spurney RF
Am J Physiol Renal Physiol; 2017 Aug; 313(2):F430-F439. PubMed ID: 28490532
[TBL] [Abstract][Full Text] [Related]
20. p27(Kip1) Knockout mice are protected from diabetic nephropathy: evidence for p27(Kip1) haplotype insufficiency.
Wolf G; Schanze A; Stahl RA; Shankland SJ; Amann K
Kidney Int; 2005 Oct; 68(4):1583-9. PubMed ID: 16164635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
